A Study of Immune Response to the Human Papillomavirus Vaccine in Young Women with Inflammatory Bowel Disease

Overview

About this study

The purpose of this study is to test the immune response to the Human Papillomavirus Vaccine in girls who have inflammatory bowel disease. The vaccine may not respond well in these girls, either due to having IBD or due to the immunosuppressants used to control IBD.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Female
  • Age 9-26 years
  • Has inflammatory bowel disease (ie. Crohns disease or ulcerative colitis)

Exclusion Criteria

  • Pregnant
  • Taking corticosteroids
  • Allergy to yeast aluminum component of the HPV vaccine
  • Positive for all HPV types in the Gardasil vaccine—6, 11, 16, 18

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jeanne Tung, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions